Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhDNase timing before versus after airway clearance therapy in cystic fibrosis
NL-OMON25167Active, not recruiting
- Sponsor
- Roche
- Start
- Aug 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of dornase alfa in cystic fibrosis (CF) (2 arms), sponsored by Roche. Primary endpoint: MEF25. Started Aug 2003; status: active, not recruiting.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON25167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25167.